Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02003092
Title RX-5902 Treatment of Subjects With Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rexahn Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Rexahn site Tucson Arizona 85724 United States Details
Rexahn Site Aurora Colorado 80045 United States Details
Rexahn site Chicago Illinois 60637 United States Details
Rexahn Site Detroit Michigan 48202 United States Details
Rexahn Site Hackensack New Jersey 07601 United States Details
Rexahn Site New York New York 10065 United States Details
Rexahn Site Greenville South Carolina 29605 United States Details
Rexahn site Arlington Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field